11.4 Eye Procedures
First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
- Double Red: These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.
11.4 Eye Procedures
Antimuscarinics
Atropine sulphate
- Eye drops 1% Contains: benzalkonium chloride (Amber 1)
- Minims® Single use eye drops 1% (Amber 3)
Notes:
- Atropine Minims® single use eye drops are also recommended for sublingual use in patients with sialorrhea in Parkinson’s Disease; Consultant neurologist initiation and stabilisation only.
Cyclopentolate hydrochloride (Amber 2)
- Eye drops 1%
- Minims® Single use eye drops 0.5%, 1%
Tropicamide
- Minims® Single use eye drops 0.5%, 1%
Notes:
- Antimuscarinics dilate the pupil and relax the ciliary muscle resulting in mydriasis and cycloplegia.
- They can raise Intra Ocular Pressure (IOP) and should be used with caution in those patients susceptible to angle closure.
- Tropicamide activity is approximately 4-6 hours and makes it ideal for mydriasis prior to ophthalmological examination.
Iodine Products and products for ocular peri-operative irrigation
Acetylcholine chloride
- Injection 1%
Disodium edetate - EDTA U
- Solution 0.37%
Mydricaine U
- Formula 1
- Formula 2
Povidone Iodine
- Single Use Eye Drops Minims® 5%
Notes:
- Antiseptic prior to surgical procedures post-Trabeculectomy
Visco-elastic drugs
Sodium Hyaluronate
- Intraocular Injection 5mg/0.5mL
Ocular Diagnostic agents - Dyes
Fluorescein sodium
- Single use eye drops 2%
- Ophthalmic strip
- Injection 20% (unlicensed)
Notes:
- Fluorescein sodium is the standard preparation to detect ocular lesions and foreign bodies.
- It is used in both primary and secondary care clinic settings and it should not be prescribed for patients as it is used for diagnostic purposes only.
Rose Bengal
- Minims®, Single use eye drops 1%
Miotics
Acetylcholine chloride
- Injection 1%
Sympathomimetics
Adrenaline U
- Eye drops; adrenaline 0.01%
Note:
- To constrict vessels during Trabeculectomy surgery and reduce intraocular bleeding
Phenylephrine hydrochloride (Amber 2)
- Minims® Single use eye drops 2.5%, 10%
Notes:
- Phenylephrine hydrochloride is used for mydriasis in diagnostic procedures and pre-operative use
Phenylephrine hydrochloride with tropicamide
- Mydriasert® Ophthalmic insert, phenylephrine hydrochloride 5.4mg, tropicamide 280mcg
Notes:
- Patients with severe dry eyes may require a drop of saline to improve insert tolerance.
11.4.1 Post operative pain and inflammation
Anaesthetics,Local
Lidocaine Hydrochloride 4% with Fluorescein 0.25%
- Minims® Eye drops, single use, preservative-free
Notes:
- Ophthalmic Consultant use only
- Local anaesthetic and staining
Oxybuprocaine Hydrochloride
- Single use eye drops 0.4%
- For neonatal use only
Proxymetacaine
- Single use eye drops 0.5%
Analgesics, Non-steroidal anti-inflammatory drugs
Flurbiprofen (Amber 2)
- Ophthalmic solution 0.03%
Ketorolac (Amber 2)
- Eye drops 0.5% (Contains: benzalkonium chloride, disodium edetate)
Corticosteroids
Loteprednol etabonate
- Eye drops: Loteprednol etabonate 0.5%
Notes:
- (Apart from postoperative situation) for steroid responder patients requiring topical steroids
Emergency use
Sodium Citrate U
- Eye drops 10.11% (equivalent to citrate 6.5%)
Indication: Acid & alkali burns to the cornea
Phosphate Buffer U (Amber 2)
- Solution
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
- Double Red: These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.
Last updated by: Sheila Wood on 18-10-2018 13:05